5. Rorabaugh - Atherosclerosis And PVD Flashcards
Atherosclerosis
Arterial inflammation and the deposition of fatty plaques (atheromas) w/in the arterial wall
Blood flow it blocked
Agents to treat Hyperlipidemia
Hint, there’s 5
- HMG-CoA Reductase Inhibitors
- Niacin
- Bile Acid Binding Resins
- Ezetimbe
- Fabric Acid Derivatives
MOA of HMG CoA Reductase Inhibitors
Inhibit 3-hydroxy-3methylglutaryl coenzyme A reductase. This blocks the rate limiting stop in cholesterol formation.
Ex. Statins
MOA of Niacin
Vitamin B3, indirectly decreases LDL production in hepatocyte by inhibiting VLDL secretion
MOA of Bile Acid Binding Resins
Prevent enterohepatic reuptake of bile acids (cholesterol metabolites) which would otherwise be reabsorbed in the jejunum and be converted back into cholesterol
Ex. Colestipol and cholestyramine
MOA of Ezetimbe
Inhibits intestinal cholesterol absorption
MOA of Fibric Acid Derivatives
Binds to a nuclear transcription factor that alters the expression of specific genes involved in lipid transport/metabolism
MOA of Aspirin in Atherosclerosis
- Inhibit platelet aggregation
2. Decreases inflammation of arterial wall
Can atherosclerosis be revered?
Yes! Lifestyle changes can reverse coronary artery stenosis and significantly alter progression of CAD
Characteristics of Atherosclerotic Renal Artery Stenosis
- atherosclerosis in the renal artery, restricting blood flow
- can affect one or both kidneys
- typically found in pts who have other comorbid diseases
- with decreased renal perfusion, kidneys think that BP is low and respond by activating the RAS system to increase BP
Stages of ARAS
- Acute occlusion and 2. occlusion for days/weeks –> increased BP, elevated renin and ANG II, elimination of obstruction can normalize BP
- Occlusion for months –> renin/ANG levels are not elevated, elimination of obstruction does not normalize BP
Signs and Symptoms of ARAS
- Onset of HTN before 30 or severe after 55 yrs
- Malignant or resistant HTN
- Atrophy of kidney
- Unexplained pulmonary edema
- Unexplained congestive heart failure
Treatment goals ARAS
- Normalize BP
- Preserve renal function
- Decrease risk of adverse CV events
Treatment of ARAS
- Statins to alter lipid profile
- Anti-HTN
- Glycemic control
- Surgical option to restore blood flow
Atherosclerotic Mesenteric Artery Disease (AMAD)
Stenosis of mesenteric arteries caused by atherosclerosis